• Home
  • Stock
  • Lincoln Pharmaceuticals Fundamental Analysis
  • Lincoln Pharmaceuticals Fundamental Analysis

Lincoln Pharmaceuticals fundamental analysis

LINCOLN

HealthcareSmall

520.05

2.30 (-0.44%)
Last updated on 10 Nov, 2025 | 10:55 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Lincoln Pharmaceuticals Fundamentals

P/E Ratio

12.19

P/B Ratio

1.51

Div. Yield

0.34

Sector P/E

36.99

Sector P/B

3.63

Sec. Div. Yield

0.56

  • Lincoln Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 12.19, compared to the sector average of 36.99. Its P/B Ratio stands at 1.51, while the sector’s is 3.63. In terms of returns, the stock offers a Dividend Yield of 0.34%, which is than the sector’s 0.56%.

Lincoln Pharmaceuticals Score Card

  • Price

    Attractive

  • Growth

    Average

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Lincoln Pharmaceuticals reflects: Price – Attractive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.